Document Detail


Immunologic defects in lung cancer patients.
MedLine Citation:
PMID:  1107678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ninety-three patients with lung cancer were evaluated by delayed cutaneous hypersensitivity testing. Twenty-eight of these patients were evaluated by in vitro lymphocyte function. Thirty-three patients were evaluated prior to surgery and defects in the immune response were closely associated with unresectable disease. In vitro and in vivo studies indicate an antigen recognition defect in the cellular immune mechanisms of these patients. Preliminary studies suggest that the immunopotentiating agent Levamisole may be able to augment this defective cellular immunity in patients with lung cancer.
Authors:
E C Holmes; S H Golub
Related Documents :
2784018 - Immunologic study of human recombinant interleukin-2 (low-dose) in patients with advanc...
2784688 - Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treate...
1083318 - B and t lymphocytes in hodgkin's disease. analysis at diagnosis and following therapy.
7272208 - Response of alopecia areata to dncb: influence of auto-antibodies and route of sensitiz...
23699228 - Elevation of activated partial thromboplastin time after low-dose unfractionated heparin.
21306958 - Mimetic automatisms expressing a negative affect in two patients with temporal lobe epi...
Publication Detail:
Type:  Clinical Trial; Comparative Study; In Vitro; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  71     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1976 Feb 
Date Detail:
Created Date:  1976-03-24     Completed Date:  1976-03-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  161-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / immunology*
Clinical Trials as Topic
Dinitrochlorobenzene / immunology
Humans
Hypersensitivity, Delayed / diagnosis
Immunity, Cellular* / drug effects
Immunologic Deficiency Syndromes / diagnosis*
Immunosuppression
Levamisole / therapeutic use
Lung Neoplasms / drug therapy,  immunology*
Lymphocyte Activation
Lymphocytes / physiopathology
Middle Aged
Placebos
Prognosis
Skin Tests
Chemical
Reg. No./Substance:
0/Placebos; 14769-73-4/Levamisole; 97-00-7/Dinitrochlorobenzene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Studies on the primary structure of 14 proteins from the large subunit of Escherichia coli ribosomes...
Next Document:  Preliminary clinical experience with a new radioisotope-powered cardiac pacemaker.